Blog Archives

Blog

“It was my students’ idea…”

Warwick, NY middle school Ukulele club raises $6,000 for NETRF

June 27, 2022 No Comments

Blog

A Champion for NETRF

“Anything that I have done, and any impact I have made in support of NETRF is because of the lessons he taught me.” Erica Roberts, NETRF Champion Society Member

June 24, 2022 No Comments

Blog

“In my heart, I don’t ever want anyone to experience what we endured.”

After Leanne lost her husband of 31 years to pancreatic neuroendocrine cancer (pNETs), she sold his most beloved possession, a Bass boat, and donated half of the proceeds to NETRF. Leanne, her son Justin and their family and friends have raised more than $35,000 in Michael’s name for NETRF. She shares their story.

May 17, 2022 No Comments

Blog

New Clinical Trial Testing Chemotherapy After Surgery in High-Risk pNETs

A new phase II clinical trial is exploring the effects of two approved chemotherapy drugs administered after surgery to treat adult patients who have high-risk, well-differentiated pancreatic neuroendocrine tumors (pNETS).

April 20, 2022 No Comments

Blog

Faces of Philanthropy:
Joe Castrovinci

Joe Castrovinci has been living with NETs (and living well!) since his diagnosis in 2012. Read about his NET journey and why he and his husband have included NETRF in their estate planning.

April 19, 2022 No Comments

Blog

Brandon’s Extraordinary Legacy

He was just FUN. Simply the nicest guy – always thinking of others. Perpetually positive – he only saw the glass as ‘half full.’ He

March 23, 2022 No Comments

Blog

First World NET Forum featured NETRF-funded Researchers

The European Neuroendocrine Tumor Society (ENETS) held its 19th Annual Conference earlier this month in Barcelona, Spain. The meeting brings together physicians and researchers from throughout the world to discuss the latest research on neuroendocrine cancer. More than 1500 participants attended in person or virtually. This year the meeting included the first World NET Forum, focusing on basic and translational science. NETRF was proud to sponsor the prizes for best abstracts.

March 23, 2022 No Comments

Blog

NETRF Achieves Highest 4-Star Rating from Charity Navigator

The Neuroendocrine Tumor Research Foundation is thrilled to announce that it has achieved a 4-star rating from Charity Navigator for the seventh consecutive year for

March 3, 2022 No Comments

Blog

Gilman elected President of NETRF Board of Directors

The Neuroendocrine Tumor Research Foundation elected Todd Gillman as President of its Board of Directors at the January 2022 meeting. Gillman replaces longtime president Joseph Li, MD.

February 25, 2022 No Comments

Blog

New Clinical Trial Focuses on Targeted Alpha-Emitter Therapy of PRRT

A new phase II clinical trial is evaluating the safety and effectiveness of 212Pb-DOTAMTATE in patients who have somatostatin receptor-expressing neuroendocrine tumors but who have not received peptide receptor radionuclide therapy, or PPRT.

February 25, 2022 No Comments

About NETRF

ForPatients

For Researchers

Get Involved

Category: Blog

Categories

About NETRF

About
NETRF

For
Patients

Get
Involved